The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21.1 - Manufacture of basic pharmaceutical products
247 jobs Number of planned job losses
Announcement Date
5 January 2012
Employment effect (start)
31 January 2012
Foreseen end date
31 May 2012
Description
On January 5, pharmaceutical and chemical company Laboratoires Merck Schering-Plough announced the discontinuation of pharmaceutical activities at its plant of Eragny-sur-Epte (Oise) with 247 job cuts by May 2012.
The closure is to be seen in the frame of a 2010 restructuring plan linked to the acquisition of Schering Plough by Merck, where the company announced its intention to sell the plant of Eragny-sur-Epte before the end of 2011. Given the lack of buyers, Laboratoires Merck Schering-Plough decided to close down its pharmaceutical activities at the plant.
UPDATE, 15/02/2012 - According to recent press reports, another 74 jobs at Merck's chemical division in Eragny-sur-Epte may also go. Staff representatives' attempts to avoid the closure of the pharmacy division (pôle pharmacie) have failed and the French Ministry of Finance refused to take any action towards that direction. The unions intend to save 74 jobs in the chemical division and to obtain a maximum in terms of compensation for the other 247 layoffs in the pharmacy division.
Sources
15 February 2012: Le Parisien
1 May 2012: France 3 Naute Normandie
10 January 2012: L' Usine Nouvelle
Citation
Eurofound (2012), Laboratoire Merck Schering-Plough, Closure in France, factsheet number 72942, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/72942.
Eurofound’s ERM restructuring legislation database offers an overview of key restructuring-related regulations in the EU Member States and Norway. Its content is continuously updated to reflect any changes made by national legislators in response to, for instance, policy shifts, legal...
Can Europe still achieve its ambitions for battery manufacturing? To answer this, the article looks at data from Eurofound’s European Restructuring Monitor and explores what recent large-scale restructuring events reveal about the state of play in the EU battery sector.
This working paper offers a comprehensive methodological overview of the European Restructuring Monitor (ERM) databases. Even though the methodology has not changed over time, new categories have been added, and the way it has been used by researchers and policymakers...
This Eurofound research paper explores key trends in restructuring in recent years, highlighting the companies that announced the largest job losses and job gains in the EU. It builds on an analysis of company announcements recorded in Eurofound’s European Restructuring...
In 2023, thousands of workers in big tech lost their jobs. Meta, Amazon, Google, Apple, Microsoft and Salesforce had been considered to offer good and secure jobs up to this point. Giants of the information and communication technology (ICT) sector,...
In 2024, the automotive sector in the EU came to the fore in public and policy discussions. The focus was on the slowdown in electric vehicle (EV) sales, rising global competition, belated investments in new technologies, and the potential closure...